News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
414,821 Results
Type
Article (18349)
Company Profile (140)
Press Release (396320)
Multimedia
Podcasts (82)
Webinars (14)
Section
Business (132280)
Career Advice (995)
Deals (23610)
Drug Delivery (92)
Drug Development (41231)
Employer Resources (68)
FDA (8923)
Job Trends (10022)
News (212821)
Policy (20652)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1144)
Accelerated approval (17)
Adcomms (14)
Allergies (83)
Alliances (35752)
ALS (65)
Alzheimer's disease (666)
Antibody-drug conjugate (ADC) (128)
Approvals (9110)
Artificial intelligence (307)
Autoimmune disease (52)
Automation (20)
Bankruptcy (213)
Best Places to Work (7698)
BIOSECURE Act (15)
Biosimilars (140)
Biotechnology (61)
Bladder cancer (55)
Brain cancer (32)
Breast cancer (262)
Cancer (2005)
Cardiovascular disease (208)
Career advice (862)
Career pathing (18)
CAR-T (77)
CDC (38)
Celiac Disease (1)
Cell therapy (277)
Cervical cancer (19)
Clinical research (35718)
Collaboration (1059)
Company closure (1)
Compensation (734)
Complete response letters (36)
COVID-19 (1258)
CRISPR (56)
C-suite (559)
Cystic fibrosis (68)
Data (2517)
Decentralized trials (1)
Denatured (22)
Depression (70)
Diabetes (182)
Diagnostics (3971)
Digital health (29)
Diversity (5)
Diversity, equity & inclusion (18)
Drug discovery (157)
Drug pricing (162)
Drug shortages (16)
Duchenne muscular dystrophy (94)
Earnings (50173)
Editorial (33)
Employer branding (5)
Employer resources (62)
Events (56636)
Executive appointments (704)
FDA (10545)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (662)
Gene editing (91)
Generative AI (23)
Gene therapy (247)
GLP-1 (530)
Government (3124)
Grass and pollen (7)
Guidances (280)
Healthcare (10631)
HIV (23)
Huntington's disease (9)
IgA nephropathy (37)
Immunology and inflammation (81)
Immuno-oncology (21)
Indications (65)
Infectious disease (1387)
Inflammatory bowel disease (93)
Inflation Reduction Act (14)
Influenza (56)
Intellectual property (136)
Interviews (153)
IPO (9657)
IRA (49)
Job creations (2564)
Job search strategy (739)
JPM (32)
Kidney cancer (9)
Labor market (55)
Layoffs (285)
Leadership (13)
Legal (4763)
Liver cancer (30)
Longevity (10)
Lung cancer (262)
Lymphoma (177)
Machine learning (18)
Management (23)
Manufacturing (595)
MASH (77)
Medical device (5849)
Medtech (5878)
Mergers & acquisitions (14645)
Metabolic disorders (553)
Multiple sclerosis (61)
NASH (14)
Neurodegenerative disease (104)
Neuropsychiatric disorders (42)
Neuroscience (1194)
Neurotech (1)
NextGen: Class of 2026 (4133)
Non-profit (2675)
Now hiring (22)
Obesity (272)
Opinion (167)
Ovarian cancer (52)
Pain (130)
Pancreatic cancer (76)
Parkinson's disease (102)
Partnered (22)
Patents (271)
Patient recruitment (155)
Peanut (20)
People (42046)
Pharmaceutical (67)
Pharmacy benefit managers (23)
Phase 1 (9456)
Phase 2 (15246)
Phase 3 (13323)
Pipeline (2843)
Policy (237)
Postmarket research (1531)
Preclinical (3825)
Press Release (70)
Prostate cancer (123)
Psychedelics (27)
Radiopharmaceuticals (178)
Rare diseases (427)
Real estate (4491)
Recruiting (28)
Regulatory (15200)
Reports (22)
Research institute (1120)
Resumes & cover letters (145)
Rett syndrome (5)
RNA editing (7)
RSV (31)
Schizophrenia (87)
Series A (101)
Series B (66)
Service/supplier (14)
Sickle cell disease (59)
Special edition (16)
Spinal muscular atrophy (91)
Sponsored (21)
Startups (2153)
State (2)
Stomach cancer (5)
Supply chain (76)
Tariffs (76)
The Weekly (58)
Vaccines (391)
Venture capital (39)
Weight loss (168)
Women's health (50)
Worklife (7)
Date
Today (4)
Last 7 days (289)
Last 30 days (1139)
Last 365 days (15378)
2026 (1431)
2025 (15763)
2024 (18824)
2023 (21642)
2022 (30001)
2021 (32056)
2020 (32664)
2019 (29691)
2018 (22698)
2017 (19837)
2016 (19103)
2015 (22066)
2014 (17252)
2013 (14640)
2012 (15867)
2011 (16684)
2010 (15013)
Location
Africa (463)
Alabama (32)
Alaska (5)
Arizona (147)
Arkansas (8)
Asia (26433)
Australia (3488)
California (4784)
Canada (2336)
China (640)
Colorado (275)
Connecticut (219)
Delaware (183)
Europe (55814)
Florida (850)
Georgia (145)
Hawaii (2)
Idaho (28)
Illinois (600)
India (49)
Indiana (339)
Iowa (7)
Japan (293)
Kansas (97)
Kentucky (34)
Louisiana (17)
Maine (29)
Maryland (789)
Massachusetts (3578)
Michigan (162)
Minnesota (273)
Mississippi (3)
Missouri (63)
Montana (16)
Nebraska (17)
Nevada (45)
New Hampshire (30)
New Jersey (1836)
New Mexico (18)
New York (1292)
North Carolina (938)
North Dakota (6)
Northern California (2167)
Ohio (200)
Oklahoma (13)
Oregon (24)
Pennsylvania (1246)
Puerto Rico (13)
Rhode Island (30)
South America (718)
South Carolina (17)
Southern California (2029)
Tennessee (99)
Texas (856)
United States (19469)
Utah (107)
Vermont (1)
Virginia (199)
Washington D.C. (60)
Washington State (359)
West Virginia (4)
Wisconsin (75)
Wyoming (1)
414,821 Results for "camargo pharmaceutical services".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pharmaceutical Service Provider Vetter Pharma to Build New Manufacturing Site in Germany
Strategic Investments in the EU and US strengthen Vetter’s Global Footprint • Building permit application for German site submitted • Construction start is scheduled for the 2nd quarter 2026, with operational readiness in 2031 • Expansions in the US and Europe are included in a €1.5 billion investment plan
January 29, 2026
·
1 min read
Press Releases
Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer
December 17, 2025
·
5 min read
Deals
Premier Research Acquires Camargo Pharmaceutical Services
Premier Research announced that it has acquired Camargo Pharmaceutical Services based in Cincinnati.
May 18, 2021
·
3 min read
Deals
Camargo Pharmaceutical Services Acquires Paidion Research
Camargo Pharmaceutical Services, LLC, a leading drug development and commercial partner, announced today it will acquire Paidion Research, Inc., a global pediatric clinical research organization (CRO) based in Durham, N.C.
March 2, 2021
·
2 min read
Press Releases
Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook
January 14, 2026
·
8 min read
Press Releases
Insilico Medicine Launches Science MMAI Gym to Transform Frontier LLMs into Pharmaceutical-Grade Scientific Engines
January 22, 2026
·
1 min read
Press Releases
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager
February 3, 2026
·
2 min read
Press Releases
Targeted Genomics Launches Celiac Genetic Testing Services for Texas Physicians
February 2, 2026
·
2 min read
Press Releases
HistoIndex Partners with Houston Research Institute to Expand Advanced MASH Diagnostic Services
January 21, 2026
·
3 min read
Business
Reeves McGee Appointed Chief Commercial Officer at Camargo Pharmaceutical Services, LLC
Camargo Pharmaceutical Services, LLC, a global drug development and commercial partner, announced today the appointment of Reeves McGee as Chief Commercial Officer. In this senior leadership role, McGee will oversee the development and implementation of Camargo’s commercial strategies, its commercial organic growth initiatives and the
October 13, 2020
·
2 min read
1 of 41,483
Next
